Skip to main content
News Tag: news
Background: National Coverage Analysis
Read More
The NRG-CC005 (FORTE) Trial has Activated!
Read More
Comparing High- and Low-Dose Cisplatin for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (NRG-HN009)
Read More
New Prostate Cancer Study Testing Higher-intensity Treatment for Patients with Higher Gene Risk Scores and Lower-intensity Treatment for Patients with Lower Gene Risk Scores (NRG-GU010, the GUIDANCE trial)
Read More
The University of Michigan T32 in Cancer Care Delivery Accepts First Cohort of Pre- and Post- Doctoral Scholars
Read More
Congratulations to the NRG Oncology Members Assigned to NCI Gastrointestinal Task Forces
Read More
Congratulations to the NRG Oncology Members Assigned to NCI Gastrointestinal Task Forces
Read More
Combining Radiotherapy and Immunotherapy in Patients with Extensive Stage Small Cell Lung Cancer (NRG-LU007, “the RAPTOR Trial”)
Read More
Hypofractionated Post-Operative Prostate Bed Radiotherapy Does Not Increase Patient-Reported Toxicity for Men with Prostate Cancer
Read More
Total Androgen Suppression with Dose-Escalated Radiotherapy Does Not Improve Overall Survival in Men with Intermediate-Risk Prostate Cancer: Results Highlight Need for Biomarker Studies
Read More